[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:deficiency-acid-sphingomyelinase":3},{"name":4,"total":5,"trials":6,"biomarkers":21,"states":22},"Deficiency, Acid Sphingomyelinase",2,[7,14],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT06192576","A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)",[],"RECRUITING","2026-08-03T02:52:31.195166Z","2026-05-13T02:55:06.422855Z",{"nct_id":15,"title":16,"phases":17,"status":18,"updated_at":19,"content_modified":20},"NCT05368038","ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program",[],"ENROLLING_BY_INVITATION","2026-08-03T02:04:08.415522Z","2026-06-16T05:54:08.030731Z",[],[]]